Chembond Chemicals Ltd Q1 FY27 Earnings Analysis

Published 31 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹504 Cr

Price

177

Market Cap

₹504 Cr

P/E Ratio

15.7

Revenue Rank

Rank 3

Margin Rank

Rank 3

Earnings Summary

- Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores). - The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth.

📊 Revenue & Sales Performance

Rank 3

- Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores). - Growth strategies include geographical expansion, entering new markets, and organic growth from a larger base. - Volume growth drives most sales increases; price increases have contributed minimally. - Construction chemicals volume growth forecasted at 15-20%, water chemicals around 10% for the current year. - Water business shows fastest growth and strong order book, with new client additions driving volume increases. - Distribution and cleaning & hygiene businesses showing positive growth due to team realignment and product additions. - Despite some margin pressure due to input cost inflation, long-term growth momentum is expected to continue, supported by industry growth and new business wins.

📈 Profitability & Margins

Rank 3

- The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth. - Volume growth is expected to drive sales, with construction chemicals projected at 15-20% and water chemicals around 10% volume growth. - EBITDA margins may face slight pressure (~3%) due to input cost volatility but could stabilize as higher-priced contracts are locked in. - Profit growth is linked closely to sales volume increases and operational efficiencies rather than price hikes, as price growth contributed minimally historically. - The water business remains the largest contributor (~85-87%), with plans to reduce its share by growing other segments faster, diversifying revenue streams. - Integration of cleaning & hygiene and water treatment technologies is expected to improve margins and growth trajectory. - Overall, earnings and profits are forecasted to improve steadily with sales growth, despite temporary margin pressures from raw material cost fluctuations.

🏗️ Capital Expenditure Plans

Yes

- Current year CAPEX has increased to around ₹20-21 crores, mainly due to the full-year impact of the demerger, including assets transferred to their books and office building renovations. - Preparing for potential adverse scenarios with readiness for all eventualities. - No plans for major new plant setups or large-scale capital investments beyond current year CAPEX. - Intend to deploy some funds in network growth and geographical expansion. - Focus on expanding existing capacity and improving infrastructure rather than greenfield projects currently.

💰 Fundraising & Capital Structure

No information

- No immediate plans for new fundraising through debt or equity. - The company is currently preparing for worst-case scenarios due to uncertain market conditions. - Available funds (around Rs. 65 crores) are planned to be deployed for network growth and geographical expansion. - No major additional plant or CapEx deployment beyond the current year is planned at this time.

📋 Order Book & Pipeline

Yes

- The Water Business Unit (BU) is entering the period with a strong order book for both chemicals and equipment. - There are ongoing activities and developments in the bioremediation space, with expectations of increased contributions from the wastewater treatment subsection. - New client additions have driven volume growth in the water chemicals business, with contracts extending till mid of the current financial year. - Several public sector contracts have come up for tendering, with bids already submitted at higher prices. - The company is actively pursuing new market opportunities and expanding geographically to increase its order book.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

Yes

Frequently Asked Questions

What were Chembond Chemicals Ltd Q1 FY27 results?

- Company aspires to reach ₹1000 crore sales within four years, aiming for nearly triple current sales (~₹330-340 crores). - The company aims to triple sales to ₹1000 crores within four years through geographical expansion, new market activation, and organic growth.

What is Chembond Chemicals Ltd share price analysis?

Chembond Chemicals Ltd currently shows a below-average growth signal. The stock trades at a P/E of 15.7 with a market cap of ₹504. Investors should review the full earnings analysis for detailed insights.

Is Chembond Chemicals Ltd planning capital expenditure?

- Current year CAPEX has increased to around ₹20-21 crores, mainly due to the full-year impact of the demerger, including assets transferred to their books and office building renovations.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

What Chembond Chemicals Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Aether Industries Ltd (Q1 FY27)

    Aether Industries Ltd Q1 FY27 quarterly results analysis. - Targeting 70% revenue from CRAMS and CEM and around 30% from Large Scale Manufacturing (LSM) in the

  • Sacheerome Ltd (Q1 FY27)

    Sacheerome Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹744, P/E 31.1. AI-po

  • Solar Industries India Ltd (Q1 FY27)

    Solar Industries India Ltd Q1 FY27 quarterly results analysis. - Targeting INR14,000 crores revenue in FY '27, marking strong growth from previous years. Market

  • SRF Ltd (Q1 FY27)

    SRF Ltd Q1 FY27 quarterly results analysis. No information is provided regarding the same in the latest conference call. Market Cap ₹79,723, P/E 41.9. AI-powere